{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:18:56Z","timestamp":1772165936257,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Projects Coordination Unit of Manisa Celal Bayar University","award":["2023-111"],"award-info":[{"award-number":["2023-111"]}]},{"name":"Scientific Research Projects Coordination Unit of Manisa Celal Bayar University","award":["2023-111"],"award-info":[{"award-number":["2023-111"]}]},{"name":"Scientific Research Projects Coordination Unit of Manisa Celal Bayar University","award":["2023-111"],"award-info":[{"award-number":["2023-111"]}]},{"name":"Scientific Research Projects Coordination Unit of Manisa Celal Bayar University","award":["2023-111"],"award-info":[{"award-number":["2023-111"]}]},{"name":"Scientific Research Projects Coordination Unit of Manisa Celal Bayar University","award":["2023-111"],"award-info":[{"award-number":["2023-111"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-025-01992-4","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:03:07Z","timestamp":1764169387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inflammatory and neuroimmune imbalance in diabetic incontinence: insights from serum biomarker profiling"],"prefix":"10.1186","volume":"25","author":[{"given":"Ali Can","family":"Albaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Kosova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6khan","family":"Temelta\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oktay","family":"\u00dc\u00e7er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talha","family":"M\u00fcezzi\u0307no\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"1992_CR1","volume-title":"Incontinence","author":"P Abrams","year":"2017","unstructured":"Abrams P, Cardozo L, Wagg A, Wein A. Incontinence. 6th ed. Bristol: ICI-ICS; 2017.","edition":"6"},{"issue":"3","key":"1992_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/13697137.2018.1543263","volume":"22","author":"I Milsom","year":"2019","unstructured":"Milsom I, Gyhagen M. The prevalence of urinary incontinence. Climacteric. 2019;22(3):217\u201322.","journal-title":"Climacteric"},{"issue":"3","key":"1992_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.4274\/jus.2090","volume":"5","author":"B Irer","year":"2018","unstructured":"Irer B, Sen V, Bozkurt O, et al. Prevalence and possible risk factors of overactive bladder symptoms in women living in the City of \u0130zmir. J Urol Surg. 2018;5(3):180\u20137.","journal-title":"J Urol Surg"},{"issue":"1","key":"1992_CR4","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s00192-012-1743-x","volume":"23","author":"VA Minassian","year":"2012","unstructured":"Minassian VA, Yan X, Lichtenfeld MJ, Sun H, Stewart WF. The iceberg of health care utilization in women with urinary incontinence. Int Urogynecol J. 2012;23(1):1087\u201393.","journal-title":"Int Urogynecol J"},{"issue":"2","key":"1992_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.semnephrol.2005.09.009","volume":"26","author":"F Daneshgari","year":"2006","unstructured":"Daneshgari F, Moore C. Diabetic uropathy. Semin Nephrol. 2006;26(2):182\u20135.","journal-title":"Semin Nephrol"},{"issue":"1","key":"1992_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2337\/diacare.28.1.177","volume":"28","author":"JS Brown","year":"2005","unstructured":"Brown JS, Wessells H, Chancellor MB, et al. Urologic complications of diabetes. Diabetes Care. 2005;28(1):177\u201385.","journal-title":"Diabetes Care"},{"key":"1992_CR7","first-page":"140","volume":"23","author":"WC Lee","year":"2004","unstructured":"Lee WC, Wu HP, Tai TY. Risk factors for urinary incontinence among middle-aged women. Taiwan J Public Health. 2004;23:140\u20135.","journal-title":"Taiwan J Public Health"},{"issue":"2","key":"1992_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1152\/physrev.00030.2012","volume":"93","author":"LA Birder","year":"2013","unstructured":"Birder LA, Andersson KE. Urothelial signaling. Physiol Rev. 2013;93(2):653\u201380.","journal-title":"Physiol Rev"},{"issue":"2","key":"1992_CR9","first-page":"105","volume":"20","author":"N Aizawa","year":"2013","unstructured":"Aizawa N, Homma Y, Igawa Y. Influence of oxidative stress on lower urinary tract symptoms. Int J Urol. 2013;20(2):105\u201311.","journal-title":"Int J Urol"},{"key":"1992_CR10","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.urology.2018.09.012","volume":"123","author":"HH Lai","year":"2019","unstructured":"Lai HH, Smith AR, Wiseman JB, et al. Relationship between central obesity, overactive bladder, and urinary incontinence. Urology. 2019;123:34\u201343.","journal-title":"Urology"},{"issue":"1","key":"1992_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2012.11.009","volume":"280","author":"D Vandamme","year":"2012","unstructured":"Vandamme D, Landuyt B, Luyten W, Schoofs L. A comprehensive summary of LL-37, the factotum human Cathelicidin peptide. Cell Immunol. 2012;280(1):22\u201335.","journal-title":"Cell Immunol"},{"issue":"9","key":"1992_CR12","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1096\/fj.04-3284com","volume":"19","author":"AF Gombart","year":"2005","unstructured":"Gombart AF, Borregaard N, Koeffler HP. Human Cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor. FASEB J. 2005;19(9):1067\u201377.","journal-title":"FASEB J"},{"issue":"5","key":"1992_CR13","first-page":"584","volume":"29","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhang W, Sun W, et al. Vitamin D deficiency and urinary incontinence: a systematic review and meta-analysis. Menopause. 2022;29(5):584\u201392.","journal-title":"Menopause"},{"issue":"2","key":"1992_CR14","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.biochi.2007.10.009","volume":"90","author":"B Korkmaz","year":"2008","unstructured":"Korkmaz B, Moreau T, Gauthier F. Neutrophil elastase, proteinase 3, and cathepsin G: physiopathological functions. Biochimie. 2008;90(2):227\u201342.","journal-title":"Biochimie"},{"issue":"2","key":"1992_CR15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/SHK.0000000000000845","volume":"48","author":"T Wang","year":"2017","unstructured":"Wang T, Zhu Z, Liu Z, et al. Plasma neutrophil elastase and Elafin as prognostic biomarkers for ARDS: a multicenter survival study. Shock. 2017;48(2):168\u201374.","journal-title":"Shock"},{"issue":"1","key":"1992_CR16","first-page":"e13258","volume":"13","author":"H Zetterberg","year":"2021","unstructured":"Zetterberg H, Blennow K. Amyloid biomarkers for alzheimer\u2019s disease. EMBO Mol Med. 2021;13(1):e13258.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"1992_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12974-020-01873-7","volume":"17","author":"Y Li","year":"2020","unstructured":"Li Y, Dutta S, Heydari B, et al. Peripheral amyloid-\u03b2 levels and associations with inflammation and insulin resistance in diabetes. J Neuroinflammation. 2020;17(1):199.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"1992_CR18","first-page":"213","volume":"28","author":"H Kume","year":"2021","unstructured":"Kume H, Iguchi T, Takahashi Y, et al. Biomarker discovery and validation in urology: challenges and opportunities. Int J Urol. 2021;28(3):213\u201322.","journal-title":"Int J Urol"},{"key":"1992_CR19","first-page":"890324","volume":"9","author":"F Lami","year":"2022","unstructured":"Lami F, Parnetti L, Pantano P, et al. Multi-biomarker panels in precision medicine: translational perspectives. Front Mol Biosci. 2022;9:890324.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"1992_CR20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3390\/biomedicines11041078","volume":"11","author":"C Arienti","year":"2023","unstructured":"Arienti C, Zambelli L, Tesei A. Proteomics and metabolomics in urological diseases: state of the Art and future perspectives. Biomedicines. 2023;11(4):1078.","journal-title":"Biomedicines"},{"issue":"2","key":"1992_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175\u201391.","journal-title":"Behav Res Methods"},{"key":"1992_CR22","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3389\/fpsyg.2013.00863","volume":"4","author":"D Lakens","year":"2013","unstructured":"Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863.","journal-title":"Front Psychol"},{"issue":"5","key":"1992_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/biof.1225","volume":"41","author":"K Bandurska","year":"2015","unstructured":"Bandurska K, Berdowska A, Barczy\u0144ska-Felusiak R, Krupa P. Unique features of human Cathelicidin LL-37. BioFactors. 2015;41(5):289\u2013300.","journal-title":"BioFactors"},{"issue":"6","key":"1992_CR24","first-page":"1432","volume":"40","author":"W Choi","year":"2021","unstructured":"Choi W, Lee YS, Lee HJ, et al. Cathelicidin LL-37 and bladder epithelial dysfunction in women with lower urinary tract symptoms. Neurourol Urodyn. 2021;40(6):1432\u201340.","journal-title":"Neurourol Urodyn"},{"key":"1992_CR25","first-page":"45","volume":"204","author":"X Chen","year":"2019","unstructured":"Chen X, Yin L, Liu Y, et al. Elafin levels in interstitial cystitis and bacterial urinary tract infection: diagnostic and Immunologic significance. Clin Immunol. 2019;204:45\u201352.","journal-title":"Clin Immunol"},{"key":"1992_CR26","first-page":"643776","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, DeWilde A, Wei B, et al. Elafin: an essential regulator of inflammation and immune response. Front Immunol. 2021;12:643776.","journal-title":"Front Immunol"},{"key":"1992_CR27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neulet.2018.07.037","volume":"684","author":"K Gholami","year":"2018","unstructured":"Gholami K, Golab F, Ramezani M, et al. Amyloid-beta 42 involvement in peripheral nerve damage in diabetes: an experimental study. Neurosci Lett. 2018;684:145\u201351.","journal-title":"Neurosci Lett"},{"key":"1992_CR28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13195-020-00627-0","volume":"12","author":"T Wisniewski","year":"2020","unstructured":"Wisniewski T, Drummond E. Amyloid-\u03b2 oligomers and Tau in alzheimer\u2019s disease and other neurodegenerative diseases: links and molecular mechanisms. Alzheimers Res Ther. 2020;12:59.","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"1992_CR29","first-page":"1471","volume":"54","author":"SJ Lee","year":"2022","unstructured":"Lee SJ, Lee HJ, Choi Y, et al. Amyloid beta in the urine of diabetic women with overactive bladder: a potential diagnostic biomarker. Int Urol Nephrol. 2022;54(6):1471\u20137.","journal-title":"Int Urol Nephrol"},{"key":"1992_CR30","doi-asserted-by":"publisher","first-page":"105552","DOI":"10.1016\/j.jsbmb.2019.105552","volume":"198","author":"MB Lowry","year":"2020","unstructured":"Lowry MB, Guo C, Zhang Y, et al. A mouse model for vitamin D-induced human Cathelicidin antimicrobial peptide gene expression. J Steroid Biochem Mol Biol. 2020;198:105552.","journal-title":"J Steroid Biochem Mol Biol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01992-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01992-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01992-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:03:09Z","timestamp":1764169389000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01992-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1992"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01992-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7479351\/v1","asserted-by":"object"}]},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Institutional Clinical Research Ethics Committee of Manisa Celal Bayar University, Faculty of Medicine (approval no: 20.478.486\/2040, dated 11 October 2023) and conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"297"}}